GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » ROA %

Bangkok Genomics Innovation PCL (BKK:BKGI) ROA % : 20.86% (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Bangkok Genomics Innovation PCL's annualized Net Income for the quarter that ended in Mar. 2023 was ฿62.50 Mil. Bangkok Genomics Innovation PCL's average Total Assets over the quarter that ended in Mar. 2023 was ฿299.53 Mil. Therefore, Bangkok Genomics Innovation PCL's annualized ROA % for the quarter that ended in Mar. 2023 was 20.86%.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's ROA % or its related term are showing as below:

BKK:BKGI' s ROA % Range Over the Past 10 Years
Min: 5.25   Med: 23.5   Max: 73.99
Current: 5.25

During the past 5 years, Bangkok Genomics Innovation PCL's highest ROA % was 73.99%. The lowest was 5.25%. And the median was 23.50%.

BKK:BKGI's ROA % is ranked better than
77.54% of 236 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.85 vs BKK:BKGI: 5.25

Bangkok Genomics Innovation PCL ROA % Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL ROA % Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
- 16.23 73.99 30.76 10.83

Bangkok Genomics Innovation PCL Quarterly Data
Dec20 Dec21 Mar22 Dec22 Mar23 Dec23
ROA % Get a 7-Day Free Trial - 59.91 - 20.86 -

Competitive Comparison of Bangkok Genomics Innovation PCL's ROA %

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL's ROA % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's ROA % distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's ROA % falls into.



Bangkok Genomics Innovation PCL ROA % Calculation

Bangkok Genomics Innovation PCL's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=32.142/( (300.577+293.021)/ 2 )
=32.142/296.799
=10.83 %

Bangkok Genomics Innovation PCL's annualized ROA % for the quarter that ended in Mar. 2023 is calculated as:

ROA %=Net Income (Q: Mar. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=62.496/( (300.577+298.477)/ 2 )
=62.496/299.527
=20.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2023) net income data. ROA % is displayed in the 30-year financial page.


Bangkok Genomics Innovation PCL  (BKK:BKGI) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2023 )
=Net Income/Total Assets
=62.496/299.527
=(Net Income / Revenue)*(Revenue / Total Assets)
=(62.496 / 305.532)*(305.532 / 299.527)
=Net Margin %*Asset Turnover
=20.45 %*1.02
=20.86 %

Note: The Net Income data used here is four times the quarterly (Mar. 2023) net income data. The Revenue data used here is four times the quarterly (Mar. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Bangkok Genomics Innovation PCL ROA % Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).

Bangkok Genomics Innovation PCL (BKK:BKGI) Headlines